NORWALK, Conn., Oct. 19, 2023 /PRNewswire/ -- GeniusBOS today announced that the company has received orders for medium voltage transformers for delivery in the United States. The company is focused on further developing this important product category. GeniusBOS Receives Orders For Medium Voltage Transformers Andrew Worden, CEO of GeniusBOS, stated: "Our customers expressed that transformers are too expensive, lead times are too long, and service levels are p

PR Newswire Oct. 19, 2023

The Cooperative Research and Development Agreement (CRADA) will focus on LFP battery recycling and Graphite recovery solutions from end-of-life lithium-ion batteries GOLDEN, Colo., Oct. 18, 2023 /PRNewswire/ -- ACE Green Recycling (ACE) and the U.S. Department of Energy's National Renewable Energy Laboratory (NREL) have signed a Cooperative Research and Development Agreement (CRADA) to further develop and optimize ACE's environment friendly and low cost lithium-ion battery recycling technology

PR Newswire Oct. 19, 2023

TAIPEI, Oct. 18, 2023 /PRNewswire/ -- GIGABYTE, a leader in cloud computing and AI server markets, announced a new strategic framework for AI outlining a blueprint for the company's direction in the AI-driven future of the consumer PC market. The framework features three fundamental pillars: offering a comprehensive AI operating platform, implementing AI-based product design, and engaging in the AI ecosystem with the goal of introducing consumers to a new AI-driven experience.

PR Newswire Oct. 19, 2023

CJ Foods and T&R Biofab aim to synergize their unique expertise and technologies to bring to the market innovative food products SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- CJ Foods, a business unit of South Korea-based CJ CheilJedang, announced that it entered into a joint development agreement (JDA) with T&R Biofab to develop alternative meat using 3D bioprinting technology. T&R Biofab is a med-tech company that develops artificial tissues using its world-class technology

PR Newswire Oct. 19, 2023

With a dedicated booth in the main exhibition hall, SK pharmteco solidifies its global position as the most trusted CDMO partner in the pharmaceutical industry Appoints Chief Commercial Officer Andrew Fenny to strengthen its global marketing capabilities Shortlisted as a finalist for the 2023 CPHI Pharma Awards in the Accelerating Innovation category RANCHO CORDOVA, Calif. and KING OF PRUSSIA, Pa., Oct. 18, 2023 /PRNewswire/ -- SK pharmteco will participate at the CPHI 2023 in Bar

PR Newswire Oct. 19, 2023

PITTSBURGH, Oct. 18, 2023 /PRNewswire/ -- Kennametal Inc. (NYSE: KMT) announced today its new KCU10B turning grade, an innovative update to its KCU10 platform with an enhanced KENGold™ coating technology for edge protection. This universal cutting solution is designed for machinists in aerospace and defense, automotive, energy and general engineering markets requiring maximum output when cutting a broad range of difficult-to-machine materials. Switch up materials, not tools, wit

PR Newswire Oct. 19, 2023

BRENTWOOD, Tenn., Oct. 18, 2023 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax") today announced top-line results from a Cardiovascular Health Outcomes Analysis (HOA). This study evaluated the cardiovascular safety of CONTRAVE®/MYSIMBA®, a weight management drug. The real-world study compared CONTRAVE®/MYSIMBA® to a similar product for the purpose of measuring major adverse cardiovascular events (MACE). The primary analysis included over 24,600 patients with

PR Newswire Oct. 19, 2023

- Going Beyond Its Role as Korea's Premier K-culture Event, Cheongju Takes a Step Closer to Realizing Its Dream of Becoming a "World Craft City" CHEONGJU, South Korea, Oct. 18, 2023 /PRNewswire/ -- Over the past 45 days, we have had the privilege of encountering crafts that connect, create, and inspire love for the world. We have now found a "map of things" that will guide us confidently into an uncertain future. The topographical map of time that the Cheon

PR Newswire Oct. 19, 2023

Generative AI Labs to accelerate development of industry AI solutions with Infosys Topaz and Google Cloud generative AI technologies Infosys will train 20,000 practitioners on Google Cloud's generative AI technologies and launch Generative AI Labs to develop industry solutions and accelerate business transformation BENGALURU, India, Oct. 18, 2023 /PRNewswire/ -- Infosys (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, toda

PR Newswire Oct. 19, 2023

HONG KONG, Oct. 18, 2023 /PRNewswire/ -- Running from October 18 to 21, Phase 2 of the 2023 Global Sources Hong Kong Shows sets the stage for an extraordinary convergence of global innovation, encompassing Mobile Electronics, Smart Home, Security & Appliances, Home & Kitchen, and Lifestyle. The shows feature an impressive lineup of more than 2,000 exhibitors across 3,900-plus booths.  Global Sources Hong Kong Shows 2023 Phase 2 features an impressive lineup of more than 2

PR Newswire Oct. 19, 2023

CHANGSHA, China, Oct. 18, 2023 /PRNewswire/ -- Located in the Northwestern of Saudi Arabia, NEOM, a $500 billion giga-project launched in 2017, is SANY Group's (SANY) most significant project in the Middle East with a total of about 2,500 units of machines projected to be deployed in the construction. As the centerpiece of 'Saudi Vision 2030', an ambitious plan by the Saudi Arabian government to transform the country's economy, NEOM will not just be a place, but a home for people who

PR Newswire Oct. 19, 2023

The IT market researcher adds 45 years of experience to the OpenLegacy Advisory board to help the company shape its unique cloud-native legacy systems integration strategy. PRINCETON, N.J., Oct. 18, 2023 /PRNewswire/ -- OpenLegacy, the leader in legacy systems integration and modernization platforms, announced today the nomination of Massimo Pezzini as their advisory board member. Mr. Pezzini joins the company's advisory board after spending over 45 years in the IT industry. He spent 25 year

PR Newswire Oct. 18, 2023

SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to October 26th. Yuyu Pharma to attend ‘CPHI Worldwide 2023’ The Yuyu Business Development team will be able to meet great partners at booth #7G30 in the Korean Trade Association pavilion to introduce Yuyu's export products such as its modified new drug Maxmarvil EC Tablet, Yuhylyx soft capsules, Yuvaro, and Senuvela Tab, among others.  In pa

PR Newswire Oct. 18, 2023